Skip to content

Pain Ease Spray in Reducing Needle Pain Associated With Intravenous Insertion in Children

Efficacy of Pain Ease Spray in Reducing Needle Pain Associated With Intravenous Insertion in Children

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00130650
Enrollment
80
Registered
2005-08-16
Start date
2006-05-31
Completion date
2006-09-30
Last updated
2008-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

IV, cannulation, Injections, Intravenous

Brief summary

The purpose of this study is to investigate the use of a new vapocoolant spray, Pain Ease, to reduce intravenous (IV) insertion pain in school-aged children receiving treatment in the Emergency Department.

Detailed description

Inserting a needle into a child's vein is a distressing experience for children. Reducing the pain of injection and avoiding the child's discomfort remains an important aim for both parents and health care workers. Withdrawing blood and intravenous insertion (IV) in children is also time consuming, especially when the child is uncooperative and stressed. We, the researchers at Children's Hospital of Eastern Ontario, have been searching for an effective, rapid and inexpensive method to alleviate the distress associated with venipuncture and IV insertion. Medications by mouth, such as anti-anxiety drugs, are helpful but usually do not significantly reduce the pain. The most commonly used anti-anxiety drug at our institution is midazolam, but unfortunately onset of action takes 20-30 minutes. There are various forms of topical creams that can numb the skin. EMLA, a mixture of two local anesthetics (Lidocaine 2.5% and Prilocaine 2.5%), is applied as a topical cream and is covered with an occlusive dressing. It requires at least 1 hour to be effective. It is not only time consuming but expensive (\ $1.30 per application). Ametop (Tetracaine PH. Eur.4%w/w) is another effective topical cream, which works in 30 minutes, but it is more expensive than EMLA (\ $3.00 per application). Vapocoolant sprays applied for \ 10 seconds immediately before injection have been shown to be faster, less expensive and as effective as EMLA in reducing pain at the site of injection during immunization. The current investigation will evaluate the quality, efficacy and costs associated with the use of a new vapocoolant spray, Pain Ease, in reducing pain associated with IV insertion for school age children.

Interventions

DEVICEPain Ease

Sponsors

Children's Hospital of Eastern Ontario
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* 6-12 years old * Require an IV inserted in less than 30 minutes

Exclusion criteria

* Allergy to vapocoolant sprays * Vascular impairment * Diabetes mellitus * Developmental delay/inability to understand pain scale * Received analgesia in last 24 hours * Triaged as resuscitation

Design outcomes

Primary

MeasureTime frame
pain scoreat injection (< 1 minute)

Secondary

MeasureTime frame
anxiety scoreat injectiong (< 1 minute)
satisfaction (nurse, parent)<10 minutes post-injection
IV insertion timeimmediate
ease of IV insertionimmediate

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026